Clara Natoli
Clara Natoli
Department of Medical, Oral and Biotechnological Sciences and CeSI-MeT University G. D'Annunzio
Email verificata su
Citata da
Citata da
Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?
GA Rabinovich, LG Baum, N Tinari, R Paganelli, C Natoli, FT Liu, ...
Trends in immunology 23 (6), 313-320, 2002
Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases.
P Patrignani, MR Panara, A Greco, O Fusco, C Natoli, S Iacobelli, ...
Journal of Pharmacology and Experimental Therapeutics 271 (3), 1705-1712, 1994
Concentrations of galectin-3 in the sera of normal controls and cancer patients
I Iurisci, N Tinari, C Natoli, D Angelucci, E Cianchetti, S Iacobelli
Clinical cancer research 6 (4), 1389-1393, 2000
Galectin‐3 overexpression protects from apoptosis by improving cell adhesion properties
P Matarrese, O Fusco, N Tinari, C Natoli, FT Liu, ML Semeraro, W Malorni, ...
International journal of cancer 85 (4), 545-554, 2000
The secreted tumor-associated antigen 90K is a potent immune stimulator
A Ullrich, I Sures, M D'Egidio, B Jallal, TJ Powell, R Herbst, A Dreps, ...
Journal of Biological Chemistry 269 (28), 18401-18407, 1994
90K (Mac-2 BP) and galectins in tumor progression and metastasis
A Grassadonia, N Tinari, I Iurisci, E Piccolo, A Cumashi, P Innominato, ...
Glycoconjugate journal 19 (7), 551-556, 2002
Galectin‐3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis
P Matarrese, N Tinari, ML Semeraro, C Natoli, S Iacobelli, W Malorni
FEBS letters 473 (3), 311-315, 2000
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable
A Cortellini, M Bersanelli, S Buti, K Cannita, D Santini, F Perrone, R Giusti, ...
Journal for immunotherapy of cancer 7 (1), 1-11, 2019
Prognostic value of a novel circulating serum 90K antigen in breast cancer
S Iacobelli, P Sismondi, M Giai, M d'Egidio, N Tinari, C Amatetti, ...
British journal of cancer 69 (1), 172-176, 1994
PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis
F Passiglia, G Bronte, V Bazan, C Natoli, S Rizzo, A Galvano, A Listì, ...
Oncotarget 7 (15), 19738, 2016
Gynaecomastia with cimetidine
GF Delle Fave, G Tamburrano, L De Magistris, C Natoli, ML Santoro, ...
The Lancet 309 (8025), 1319, 1977
Triple positive breast cancer: a distinct subtype?
P Vici, L Pizzuti, C Natoli, T Gamucci, L Di Lauro, M Barba, D Sergi, ...
Cancer treatment reviews 41 (2), 69-76, 2015
Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer
M Zilli, A Grassadonia, N Tinari, A Di Giacobbe, S Gildetti, J Giampietro, ...
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1795 (1), 62-81, 2009
Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to α-interferon therapy in chronic HCV hepatitis patients
M Artini, C Natoli, N Tinari, A Costanzo, R Marinelli, C Balsano, P Porcari, ...
Journal of hepatology 25 (2), 212-217, 1996
Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies
P Vici, L Pizzuti, L Mariani, G Zampa, D Santini, L Di Lauro, T Gamucci, ...
Expert review of vaccines 15 (10), 1327-1336, 2016
Synthetic inhibitors of galectin-1 and-3 selectively modulate homotypic cell aggregation and tumor cell apoptosis
IDA Iurisci, A Cumashi, AA Sherman, YE Tsvetkov, N Tinari, E Piccolo, ...
Anticancer research 29 (1), 403-410, 2009
Measurement of a breast cancer associated antigen detected by monoclonal antibody SP-2 in sera of cancer patients
S Iacobelli, E Arno, P Sismondi, C Natoli, N Gentiloni, G Scambia, M Giai, ...
Breast cancer research and treatment 11 (1), 19-30, 1988
Sunitinib malate (SU-11248) alone or in combination with low-dose docetaxel inhibits the growth of DU-145 prostate cancer xenografts
A Cumashi, N Tinari, C Rossi, R Lattanzio, C Natoli, M Piantelli, ...
Cancer letters 270 (2), 229-233, 2008
LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis
E Piccolo, N Tinari, D Semeraro, S Traini, I Fichera, A Cumashi, ...
Journal of molecular medicine 91 (1), 83-94, 2013
Lack of expression of galectin-3 is associated with a poor outcome in node-negative patients with laryngeal squamous-cell carcinoma
M Piantelli, S Iacobelli, G Almadori, M Iezzi, N Tinari, C Natoli, G Cadoni, ...
Journal of clinical oncology 20 (18), 3850-3856, 2002
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20